CRYSTAL ROGER
Insider CIK 1656633 · OPNT Chief Executive Officer, Director, 10% owner · MNMD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DFTX Definium Therapeutics, Inc | A Award deriv | 2026-06-11 | 2026-06-15 | 19,188 | — | $0 | 19,188 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-06-11 | 2026-06-15 | 4,666 | — | $0 | 24,289 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2025-06-12 | 2025-06-16 | 75,187 | — | $0 | 75,187 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2024-06-10 | 2024-06-12 | 16,506 | — | $0 | 16,506 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2023-06-21 | 2023-06-23 | 19,203 | — | $0 | 27,267 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award | 2023-06-21 | 2023-06-23 | 13,671 | — | $0 | 19,623 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 31,250 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 25,000 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 150,000 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 13,200 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 27,250 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 375,000 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 25,000 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 37,438 | $20.00 | $748.8K | 37,901 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 37,901 | $20.00 | $758.0K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2023-03-02 | 2023-03-03 | 6,667 | — | $0 | 6,667 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 6,667 | $20.00 | $133.3K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 5,100 | $20.00 | $102.0K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2023-01-27 | 2023-01-31 | 1,358 | $20.26 | $27.5K | 75,339 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2023-01-09 | 2023-01-09 | 1,183 | $20.20 | $23.9K | 76,697 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2023-01-05 | 2023-01-05 | 5,029 | $20.20 | $101.6K | 77,880 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2022-08-11 | 2022-08-15 | 120,968 | — | $0 | 120,968 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2022-08-11 | 2022-08-15 | 503,773 | — | $0 | 503,773 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award | 2022-08-11 | 2022-08-15 | 89,286 | — | $0 | 89,286 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2022-07-14 | 2022-07-15 | 2,246 | $11.11 | $25.0K | 82,909 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-06-27 | 2022-06-29 | 6,667 | — | $0 | 85,155 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2022-01-27 | 2022-01-27 | 1,995 | $26.15 | $52.2K | 78,488 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2022-01-10 | 2022-01-12 | 1,058 | $30.49 | $32.3K | 80,483 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-01-04 | 2022-01-05 | 40,000 | — | $0 | 81,541 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2021-09-16 | 2021-09-16 | 100 | $23.44 | $2.3K | 5,100 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2021-01-26 | 2021-01-27 | 31,250 | — | $0 | 31,250 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-01-26 | 2021-01-27 | 15,650 | — | $0 | 41,541 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-01-26 | 2021-01-27 | 3,766 | — | $0 | 25,891 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2020-01-07 | 2020-01-09 | 27,250 | — | $0 | 27,250 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2020-01-07 | 2020-01-09 | 13,650 | — | $0 | 22,125 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2019-04-08 | 2019-04-08 | 12,772 | $12.10 | $154.5K | 8,475 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2019-04-05 | 2019-04-08 | 21,472 | $7.25 | $155.7K | 375,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2019-04-05 | 2019-04-08 | 21,472 | $7.25 | $155.7K | 37,248 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2019-04-05 | 2019-04-08 | 16,001 | $11.98 | $191.7K | 21,247 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2019-04-04 | 2019-04-04 | 22,557 | $7.25 | $163.5K | 396,472 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2019-04-04 | 2019-04-04 | 22,557 | $7.25 | $163.5K | 32,612 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2019-04-04 | 2019-04-04 | 16,836 | $11.93 | $200.9K | 15,776 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2019-04-03 | 2019-04-04 | 5,149 | $7.25 | $37.3K | 419,029 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2019-04-03 | 2019-04-04 | 3,791 | $12.24 | $46.4K | 10,055 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2019-04-03 | 2019-04-04 | 5,149 | $7.25 | $37.3K | 14,446 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2019-04-02 | 2019-04-04 | 822 | $7.25 | $6.0K | 424,178 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2019-04-02 | 2019-04-04 | 600 | $12.48 | $7.5K | 13,846 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2019-04-02 | 2019-04-04 | 822 | $7.25 | $6.0K | 9,297 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2019-01-15 | 2019-01-17 | 13,200 | — | $0 | 13,200 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2019-01-08 | 2019-01-08 | 11,407 | $13.27 | $151.4K | 8,475 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2019-01-07 | 2019-01-08 | 8,641 | — | $0 | 425,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2019-01-07 | 2019-01-08 | 8,641 | $7.25 | $62.6K | 21,641 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2019-01-07 | 2019-01-08 | 26,759 | $13.28 | $355.4K | 19,882 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2019-01-07 | 2019-01-08 | 25,000 | $6.00 | $150.0K | 46,641 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2019-01-04 | 2019-01-08 | 25,000 | — | $0 | 50,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2019-01-04 | 2019-01-08 | 16,359 | — | $0 | 433,641 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2019-01-04 | 2019-01-08 | 16,359 | $7.25 | $118.6K | 24,834 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2019-01-04 | 2019-01-08 | 11,834 | $13.54 | $160.2K | 13,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2018-10-09 | 2018-10-10 | 6,941 | $17.04 | $118.3K | 8,475 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2018-10-08 | 2018-10-10 | 3,059 | $17.33 | $53.0K | 15,416 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2018-10-05 | 2018-10-10 | 847 | $18.14 | $15.4K | 18,475 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2018-10-04 | 2018-10-04 | 4,006 | $18.43 | $73.8K | 19,322 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2018-10-03 | 2018-10-04 | 4,300 | $19.23 | $82.7K | 23,328 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2018-10-02 | 2018-10-04 | 50,000 | — | $0 | 450,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2018-10-02 | 2018-10-04 | 29,297 | $7.25 | $212.4K | 37,772 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2018-10-02 | 2018-10-04 | 10,144 | $17.51 | $177.6K | 27,628 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2017-01-17 | 2017-01-19 | 3,475 | $6.99 | $24.3K | 8,475 | SEC↗ |